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NS4BHepatitis C virus (HCV) NS4B protein is a transmembrane highly hydrophobic protein responsible for many
key aspects of the viral replication process. The C-terminal part of NS4B is essential for replication and is a
potential target for HCV replication inhibitors. In this work we have carried out a study of the binding to
and interaction with model biomembranes of a peptide corresponding to the C-terminal domain of NS4B,
NS4BCter. We show that NS4BCter partitions into phospholipid membranes, is capable of rupturing membranes
even at very low peptide-to-lipid ratios and its membrane-activity is modulated by lipid composition. NS4B-
Cter is located in a shallow position in the membrane but it is able to affect the lipid environment from the
membrane surface down to the hydrophobic core. Our results identify the C-terminal region of the HCV
NS4B protein as a membrane interacting domain, and therefore directly implicated in the HCV life cycle
and possibly in the formation of the membranous web.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Hepatitis C virus (HCV) is an enveloped positive single-stranded
RNA virus included in the genus Hepacivirus, family Flaviviridae, and
it is the major cause of liver diseases [1,2] as well as other extra-
hepatic illnesses [3]. With approximately 170 to 200 million people
infected worldwide [1,2] and no protective vaccine available at pre-
sent, this disease has emerged as a serious global health problem on
a global scale [4,5]. Owing to high variability, HCV is classiﬁed into 7
genotypes and more than 100 subtypes [1,2]. The variability of the
HCV proteins gives the virus the ability to escape the host immune
surveillance system and notably hampers the development of an efﬁ-
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l rights reserved.HCV has a single-stranded genome which encodes a polyprotein
of about 3010 amino-acids, which is cleaved by a combination of cel-
lular and viral proteases to produce the mature structural and
non-structural proteins [6,7]. HCV entry into the host cell is achieved
by the fusion of viral and cellular membranes, the replication of its ge-
nome occurs in a membrane-associated replication complex, and
morphogenesis has been suggested to take place in endoplasmic re-
ticulum (ER) modiﬁed membranes [8]. Details about HCV replication
process remain largely unclear, but most if not all of the HCV
non-structural proteins (NS) are involved and function in a complex
web of protein–protein and protein–lipid interactions [7,9]. HCV
RNA replication requires the NS proteins that include two viral prote-
ases, NS2 and NS3, responsible for the maturation of all the NS pro-
teins [10]. The NS4A protein, an integral membrane protein, serves
as a cofactor for NS3 and is incorporated as an integral component
into the enzyme core [11]. NS5A is a membrane-anchored phospho-
protein which is indispensable for replication and it is essential for
efﬁcient virus assembly [12]. The NS5B RNA-dependent RNA poly-
merase is responsible for synthesis of the positive-sense RNA genome
via negative-strand intermediates [13].
Recent advances point to unique ties of the viral life cycle with liver
lipid metabolism and a speciﬁc lipid environment favorable for viral
replication [14,15]. Concomitantly, every step of RNA replication is con-
nected to host cell lipids, and is strongly inﬂuenced by lipid composition
and localization in speciﬁc lipid domains of viral proteins involved in in-
tracellular viral RNA replication depends on protein NS4B [16]. NS4B is
fundamental in the HCV replicative process, is the least characterized
HCV protein and is a highly hydrophobic protein associated withmem-
branes of an ER-derived modiﬁed compartment [17]. Signiﬁcantly,
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NS4B induces the formation of signiﬁcant intracellular membrane
changes, the so calledmembranous web [19], which has been postulat-
ed to be the HCV RNA replication complex. Thus, a function of NS4B
might be to induce a speciﬁc membrane alteration that serves as a scaf-
fold for the formation of the HCV replication complex and therefore has
a critical role in the HCV cycle. Due to the high hydrophobic nature of
NS4B, a detailed structure determination of this protein is very difﬁcult
and it will be hardly obtained in the near future. NS4B is likely an inte-
gral membrane protein with several transmembrane domains [17].
NS4B contains an ATP/GTPase function [20], displays anti-apoptotic ac-
tivity [21], and is palmitoylated in the C-terminal region and its
N-terminal domain has a potent polymerization activity [22]. The
C-terminal part of NS4B contains two α-helical elements, essential for
replication and potential targets for HCV replication inhibitors [23]. A
recent study has demonstrated that the C-terminal domain is crucial
for NS4B self-interaction and the formation of functional HCV replica-
tion complexes [24].
We have recently identiﬁed the membrane-active regions of a
number of viral proteins by observing the effect of peptide libraries
on model membrane integrity [25–27]. Similarly, studying the effect
of NS4B-derived peptide libraries on model membrane integrity has
helped us to understand the mechanisms underlying the interaction
between NS4B and membranes allowing us to propose the location
of different segments in NS4B that might be implicated in protein–
lipid and protein–protein interactions [26]. In the present study, we
report the interaction of a peptide corresponding to the C-terminal
domain of NS4B, NS4BCter, as well as expanded previous studies
made with NS4BH1 and NS4BH2 peptides, comparing their effect
with different membrane model systems. These results suggest that
the C-terminal region of NS4B is an essential constituent of the inter-
action between the protein and the membrane and might shed light
into the speciﬁc function of the NS4B protein in the viral cycle.
2. Materials and methods
2.1. Materials and reagents
Peptides NS4BCter (1909GEGAVQWMNRLIAFASRGNHVSPTHYVPE
SDAAARVTAILSSLTVTQLLRRLHQWISSECTTPC1972), NS4BH1 (1909GEGAVQ
WMNRLIAFASRG1926) and NS4BH2 (1947ILSSLTVTQLLRRLHQWI1964)
(HCV strain 1a_H77 polyprotein numbering) were synthesized with N-
terminal acetylation and C-terminal amidation on an automatic multiple
synthesizer (Genemed Synthesis, San Antonio, TX, USA). The peptides
werepuriﬁedby reverse-phasehigh-performance liquid chromatography
(Vydac C-8 column, 250×4.6 mm, ﬂow rate 1 ml/min, solvent A, 0.1%
triﬂuoroacetic acid, solvent B, 99.9 acetonitrile and 0.1% triﬂuoroacetic
acid) to >95% purity, and its composition and molecular mass were
conﬁrmed by amino acid analysis and mass spectroscopy. Since
triﬂuoroacetate has a strong infrared absorbance at approximately
1673 cm−1, which interferes with the characterization of the pep-
tide Amide I′ band [28], residual triﬂuoroacetic acid, used both in
peptide synthesis and in the high-performance liquid chromatogra-
phy mobile phase, was removed by four lyophilization/solubiliza-
tion cycles in 10 mM HCl [29]. Peptides were solubilized in water/
TFE at 50% (v/v). Bovine brain phosphatidylserine (BPS), bovine
liver L-α-phosphatidylinositol (BPI), cholesterol (Chol), egg L-α-
phosphatidylglycerol (EPG), egg L-α-phosphatidic acid (EPA), egg
L-α-phosphatidylcholine (EPC), egg sphingomyelin (ESM), egg trans-
phosphatidylated L-α-phosphatidylethanolamine (TPE), tetramyristoyl
cardiolipin (CL), 1,2-dimyristoylphosphatidylserine (DMPS), 1,2-dimy
ristoylphosphatidylcholine (DMPC), 1,2-dimyristoylphosphatidylglycerol
(DMPG), 1,2-dimyristoylphosphatidic acid (DMPA), liver lipid extract, N-
palmitoyl-D-erythro-sphingosylphosphorylcholine (PSM), bis(monomy
ristoylglycero)phosphate (14BMP) and bis(monooleoylglycero)phos-
phate (18BMP) were obtained from Avanti Polar Lipids (Alabaster, AL,USA). The lipid composition of the synthetic ER membrane was EPC/CL/
BPI/TPE/BPS/EPA/ESM/Chol at a molar ratio of 59:0.37:7.4:18:3.1:1.2:
3.4:7.8 [30]. The lipid composition of the synthetic late endosome mem-
brane (LEM) was EPC/TPE/BPI/18BMP at a molar ratio of 5:1:1:2 [31].
5-Carboxyﬂuorescein (CF, >95% by HPLC), 5-doxyl-stearic acid (5-NS),
16-doxyl-stearic acid (16-NS), deuterium oxide (99.9%), Triton X-100,
EDTA and HEPES were purchased from Sigma-Aldrich (Madrid, ES). 1,6-
Diphenyl-1,3,5-hexatriene (DPH), and 1-(4-trimethylammoniumphe
nyl)-6-phenyl-1,3,5-hexatriene(TMA-DPH) were obtained fromMolecu-
lar Probes (Eugene, OR). All other chemicals were commercial samples
of the highest purity available (Sigma-Aldrich, Madrid, ES). Water was
deionized, twice-distilled and passed through a Milli-Q equipment
(Millipore Ibérica, Madrid, ES) to a resistivity higher than 18 MΩ cm.
2.2. Vesicle preparation
Aliquots containing the appropriate amount of lipid in chloroform/
methanol (2:1 vol/vol) were placed in a test tube, the solvents were re-
moved by evaporation under a stream of O2-free nitrogen, and ﬁnally,
traces of solvents were eliminated under vacuum in the dark for >3 h.
The lipid ﬁlms were resuspended in an appropriate buffer and incubated
either at 25 °C or 10 °C above the phase transition temperature (Tm)with
intermittent vortexing for 30 min to hydrate the samples and obtainmul-
tilamellar vesicles (MLV). The sampleswere frozen and thawedﬁve times
to ensure complete homogenization and maximization of peptide/lipid
contacts with occasional vortexing. Large unilamellar vesicles (LUV)
with amean diameter of 0.1 μm (leakagemeasurements) were prepared
fromMLVby the extrusionmethod [32] using polycarbonateﬁlterswith a
pore size of 0.1 μm (Nuclepore Corp., Cambridge, CA, USA). For infrared
spectroscopy, aliquots containing the appropriate amount of lipid in chlo-
roform/methanol (2:1, v/v) were placed in a test tube containing 200 μg
of dried lyophilized peptide. After vortexing, the solvents were removed
by evaporation under a stream of O2-free nitrogen, and ﬁnally, traces of
solvents were eliminated under vacuum in the dark for more than 3 h.
The samples were hydrated in 100 μl of D2O buffer containing 20 mM
HEPES, 100 mM NaCl, 0.1 mM EDTA, pH 7.4 and incubated at 10 °C
above the Tm of the phospholipid with intermittent vortexing for
45 min to hydrate the samples and obtainMLV. The samples were frozen
and thawed as above. Finally the suspensions were centrifuged at
15,000 rpm at 25 °C for 10 min to remove the peptide unbound to the
membranes. The pellet was resuspended in 25 μl of D2O buffer and incu-
bated for 45 min at 10 °C above the Tm of the phospholipid, unless stated
otherwise. The phospholipid and peptide concentrations were measured
by methods described previously [33,34].
2.3. Membrane leakage and peptide binding to vesicles
LUVs with a mean diameter of 0.1 μm were prepared as indicated
above in buffer containing 10 mM Tris, 20 mM NaCl, pH 7.4, and CF at
a concentration of 40 mM. Non-encapsulated CF was separated from
the vesicle suspension through a Sephadex G-50 ﬁltration column
(Pharmacia, Uppsala, SW, EU) eluted with buffer containing 10 mM
Tris, 100 mM NaCl, 1 mM EDTA, pH 7.4. Membrane rupture (leakage
of intraliposomal CF) was assayed by treating the probe-loaded lipo-
somes (ﬁnal lipid concentration, 0.125 mM) with the appropriate
amounts of peptide on microtiter plates using a microplate reader
(FLUORstar; BMG Labtech, Offenburg, Germany), stabilized at 25 °C
with the appropriate amounts of peptide, each well containing a
ﬁnal volume of 170 μl. The medium in the microtiter plates was con-
tinuously stirred to allow the rapid mixing of peptide and vesicles.
One hundred percent release was achieved by adding Triton X-100
either to the microtiter plate or to the ﬁnal concentration of 0.5%
(w/w). Changes in ﬂuorescence intensity were recorded with excita-
tion and emission wavelengths set at 492 and 517 nm, respectively.
Excitation and emission slits were set at 5 nm. Leakage was quanti-
ﬁed on a percentage basis as previously described [35,36]. Steady-
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spectroﬂuorometer with excitation and emission wavelengths of
290 and 348 nm, respectively, and 4 nm spectral bandwidths. Mea-
surements were carried out in 10 mM Tris, 100 mM NaCl, EDTA
0.1 mM, pH 7.4. Intensity values were corrected for dilution, and the
scatter contribution was derived from lipid titration of a vesicle
blank. Peptide partitioning into membranes was evaluated by the en-
hancement of the tryptophan ﬂuorescence by successive additions of
small volumes of LUV to a peptide sample (3.4×10−5 M). The data
were analyzed and partition coefﬁcients Kp (i.e. the amount of pep-
tide bound to the bilayer as a fraction of the total peptide present in
the system) obtained as described previously [25].
2.4. Acrylamide quenching of Trp emission, quenching with lipophilic
depth probes and steady-state ﬂuorescence anisotropy
Aliquots from a 4 M solution of the water-soluble quencher were
added to the solution-containing peptide in the presence and absence
of liposomes at a peptide/lipid molar ratio of 1:100. The results
obtained were corrected for dilution and the scatter contribution
was derived from acrylamide titration of a vesicle blank. The data
were analyzed according to the Stern–Volmer equation [37]. Aliquots
of TMA-DPH or DPH in N,N′-dimethylformamide were directly added
into MLVs formed in 10 mM Tris, 100 mMNaCl, EDTA 0.1 mM, pH 7.4
to obtain a probe/lipid molar ratio of 1:500. Samples were incubated
for 15 or 60 min when TMA-DPH or DPH were used, respectively,
10 °C above the gel to liquid-crystalline phase transition temperature
Tm of the phospholipid. When the ER complex mixture was used, in-
cubation was made at 33 °C. Afterwards, the peptides were added to
obtain a peptide/lipid molar ratio of 1:15 and incubated at 10 °C
above the Tm of each lipid for 1 h, with occasional vortexing. All ﬂuo-
rescence studies were carried out using 5 mm×5 mm quartz
cuvettes in a ﬁnal volume of 400 μl (315 μM lipid concentration).
The steady state ﬂuorescence anisotropy was measured with an auto-
mated polarization accessory using a Varian Cary Eclipse ﬂuorescence
spectrometer, coupled to a Peltier for automatic temperature change.
Samples were excited at 360 nm (slit width, 5 nm) and ﬂuorescence
emission was recorded at 430 nm (slit width, 5 nm). Quenching stud-
ies with lipophilic probes were performed by successive addition of
small amounts of 5-NS or 16-NS in ethanol to peptide samples incu-
bated with LUV. The ﬁnal concentration of ethanol was kept below
2.5% (v/v) to avoid any signiﬁcant bilayer alterations. After each addi-
tion an incubation period of 15 min was kept before the measure-
ment. The data were analyzed as previously described [36]. The
Stern–Volmer quenching constant, KSV, obtained from the Stern–Volmer
equation, is the product of the lifetime in the absence of the quencher
and the quenching rate constant, and it is a measure of the accessibility
of Trp to the quencher molecule [38].
2.5. Differential scanning calorimetry
MLVs were formed as stated above in 20 mM HEPES, 100 mM NaCl,
0.1 mM EDTA, pH 7.4. The peptide was added to obtain a peptide/lipid
molar ratio of 1:15. Theﬁnal volumewas 0.8 ml (0.6 mM lipid concentra-
tion), and incubated at 10 °C above the Tm of each phospholipid for 1 h
with occasional vortexing. Differential scanning calorimetry (DSC) exper-
iments were performed in a VP-DSC differential scanning calorimeter
(MicroCal LLC, MA) under a constant external pressure of 30 psi in
order to avoid bubble formation and samples were heated at a constant
scan rate of 60 °C/h. Experimental data were corrected from small mis-
matches between the two cells by subtracting a buffer baseline prior to
data analysis. The excess heat capacity functions were analyzed using Or-
igin 7.0 (Microcal Software). The thermogramswere deﬁned by the onset
and completion temperatures of the transition peaks obtained from
heating scans. In order to avoid artifacts due to the thermal history of
the sample, the ﬁrst scan was never considered; second and furtherscans were carried out until a reproducible and reversible pattern was
obtained.
2.6. Magic angle spinning (MAS) 31P NMR
Samples were prepared as described above and concentrated by
centrifugation (14,000 rpm for 15 min). MAS 31P NMR spectra were
acquired on a Bruker 500 MHz Avance spectrometer (Bruker BioSpin,
Rheinstetten, Germany) using a Bruker 4-mm broadband MAS probe
under both static and MAS conditions. The samples were packed into
4-mm zirconia rotors and placed in the spinning module of the MAS
probe; no cross-polarization was used. The spinning speed was
8 kHz, regulated to ±3 Hz by a Bruker pneumatic unit and the tem-
perature was 20±2 °C. A single 31P 90° pulse (typically 5 μs) was
used for excitation, a gated broadband decoupling of 10 W, 32 k
data points, 3600 transients and 5 s delay time between acquisitions.
Under static conditions, the samples showed a broad asymmetrical
signal with a low-frequency peak and a high-frequency shoulder
characteristic of bilayer structures (data not shown).
2.7. Infrared spectroscopy
Approximately 25 μl of a pelleted sample in D2O was placed be-
tween two CaF2 windows separated by 56-μm thick Teﬂon spacers
in a liquid demountable cell (Harrick, Ossining, NY). The spectra
were obtained in a Bruker IFS55 spectrometer using a deuterated tri-
glycine sulfate detector. Each spectrum was obtained by collecting
250 interferograms with a nominal resolution of 2 cm−1, trans-
formed using triangular apodization and, in order to average back-
ground spectra between sample spectra over the same time period,
a sample shuttle accessory was used to obtain sample and back-
ground spectra. The spectrometer was continuously purged with
dry air at a dew point of −40 °C in order to remove atmospheric
water vapor from the bands of interest. All samples were equilibrated
at the lowest temperature for 20 min before acquisition. An external
bath circulator, connected to the infrared spectrometer, controlled
the sample temperature. For temperature studies, samples were
scanned using 2 °C intervals and a 2-min delay between each consec-
utive scan. The data were analyzed as previously described [25,26].
3. Results
As shown in Table 1, the C-terminal region of NS4B is signiﬁcantly
conserved among the major genotypes of HCV indicating that this se-
quence is likely an important region in NS4B protein. Furthermore,
the C-terminal region contains two proposed α-helical elements, re-
gions H1 and H2 [25,26]. Due to the signiﬁcant role this C-terminal re-
gion could have in the biological function of the protein, we have
studied the binding and interaction of a peptide comprising the
C-terminal region of NS4B, NS4BCter, with different membrane
model systems as well as characterized the structural changes taking
place in the peptide and in the membrane. Finally, we have compared
the results obtained with those peptides pertaining to the two
proposed α-helical elements of the C-terminal region, NS4BH1 and
NS4BH2 peptides.
The ability of the NS4BCter peptide to interact with membranes
was determined from ﬂuorescence studies of the peptide's intrinsic
Trp [39] using liposomes containing different phospholipid composi-
tions at different lipid/peptide ratios (Fig. 1A). In the case of the
NS4BCter peptide, partition constant (Kp) values in the range 105–
106 were obtained for the different phospholipid compositions stud-
ied (Table 2), indicating that the peptide was bound to the mem-
brane surface with high afﬁnity [39]. Interestingly, the highest Kp
values were obtained for membrane compositions containing Chol
(Fig. 1A). The accessibility of the Trp residue of the NS4BCter peptide
to the aqueous environment before and after binding to membranes
Table 1
Alignment (ClustalW) of residues 1909–1972 (1a_H77 polyprotein numbering) from reference strains representing the major genotypes of Hepatitis C virus as well as the NS4BCter,
NS4BH1 and NS4BH2 peptides examined in this work. The consensus sequence is shown beneath the alignment.
Strain Sequence
1a-H77 GEGAVQWMNRLIAFASRGNHVSPTHYVPESDAAARVTAILSSLTVTQLLRRLHQWISSECTTPC
1c-HC_G9 GEGAVQWMNRLIAFASRGNHVSPTHYVPESDASVRVTHILTSLTVTQLLKRLHVWISSDCTAPC
1g-1804 GEGAVQWMNRLIAFASRGNHVSPTHYVHEDDAAKRVTAILSSLTVTQLLRRLHTWINEDCTTPC
1b-RB_Con1 GEGAVQWMNRLIAFASRGNHVSPTHYVPESDAAARVTQILSSLTITQLLKRLHQWINEDCSTPC
1b-HC_J4 GEGAVQWMNRLIAFASRGNHVSPTHYVPESDAAARVTQILSSLTITQLLKRLHQWINEDCSTPC
3a-NZL1 GEGAVQWMNRLIAFASRGNHVSPTHYVPESDAAARVTALLSSLTVTSLLRRLHQWINEDYPSPC
3b-Tr_Kj GEGAVQWMNRLIAFASRGNHVSPTHYVPESDAAAKVTALLSSLTVTRLLRRLHQWINEDYPSPC
3k-JK049 GEGAVQWMNRLIAFASRGNHVAPTHYVPESDAAAKVTALLSSLTVTQLLRRLHQWINEDYPTPC
4f-CM_DAV9905 GEGAVQWMNRLIAFASRGNHVSPTHYVPESDAAARVTAILSSLTVTSLLRRLHKWINEDCPTPC
4b-P026 GEGAVQWMNRLIAFASRGNHVSPTHYVPETDAAARVTAILSSLTVTSLLKRLHKWINEDCSTPC
4k-PB65185 GEGAVQWMNRLIAFASRGNHVSPTHYVPETDAAARVTAILSSLTVTSLLRRLHKWINEDCSTPC
4d-24 GEGAVQWMNRLIAFASRGNHVAPTHYVPETDAAARVTTILSSLTVTSLLRRLHKWINEDCSTPC
4a-ED43 GEGAVQWMNRLIAFASRGNHVSPTHYVPESDAARRVTTILSSLTVTSLLRRLHKWINEDCSTPC
2c-BEBE1 GEGAVQWMNRLIAFASRGNHVAPTHYVAESDASQRVTQLLGSLTITSLLRRLHQWITEDCPVPC
2k-VAT96 GEGAVQWMNRLIAFASRGNHVAPTHYVAESDASQRVTQLLGSLTITSLLRRLHTWITEDCPVPC
2a-HC_J6 GEGAVQWMNRLIAFASRGNHVAPTHYVTESDASQRVTQLLGSLTITSLLRRLHNWITEDCPIPC
2b-HC_J8 GEGAVQWMNRLIAFASRGNHVAPTHYVVESDASQRVTQVLSSLTITSLLRRLHAWITEDCPVPC
2i-D54 GEGAVQWMNRLIAFASRGNHVAPTHYVTESDASKRVTELLSSLTITSLLRRLHQWISEDYPVPC
5a-EUH1480 GEGAVQWMNRLIAFASRGNHGSPTHYVPETDASAKVTQLLSSLTVTSLLKRLHTWIGEDYSTPC
6f-C_0044 SEGANQWMNRLIAFASRGNHVSPTHYVPETDASVAVTKILSSLTITSLLRRLHEWINGDWTTPC
6q-QC099 SEGANQWMNRLIAFASRGNHVSPTHYVPETDASKAVTTILSSLTITSLLRRLHEWINGDWTTPC
6p-QC216 SEGATQWMNRLIAFASRGNHVSPTHYVPETDASRAVMAILSSLTITSLLRRLHEWINGDWTTPC
6e-D42 SEGAAQWMNRLIAFASRGNHVSPTHYVPETDASRAVTNILSSLTITSLLRRLHNWINGDWTTPC
6d-VN235 SEGATQWMNRLIAFASRGNHVSPTHYVPETDASRAVTTILSSLTITSLLRRLHEWISGDWSAPC
6t-D49 TEGAAQWMNRLIAFASRGNHVSPTHYVPETDASRAVTTILSSLTITSLLRRLHEWISGDWTTPC
6l-D33 AEGATQWMNRLIAFASRGNHVSPTHYVPETDTSRQITTILSSLTITSLLRKLHEWVNGDWSTPC
6n-D86_93 AEGATQWMNRLIAFASRGNHVSPTHYVPETDTSRQIMTILSSLTITSLLRKLHEWINSDWSTPC
6h-VN004 SEGATQWMNRLIAFASRGNHVSPTHYVPETDTSRQIMTILSSLTVTSLLRKLHEWINTDWSTPC
6k-VN405 AEGATQWMNRLIAFASRGNHVSPTHYVPETDTSRQVMAILSSLTVTSLLRKLHEWINSDWSTPC
6m-B4_92 TEGATQWMNRLIAFASRGNHVSPTHYVPETDASRQVMAILSSLTITSLLRKLHEWINTDWTTPC
6o-D85 SEGATQWMNRLIAFASRGNHVSPTHYVPETDASKNVMTILSSLTITSLLRKLHEWINSDWSTPC
6i-C_0159 SEGATQWMNRLIAFASRGNHVSPTHYVPETDASQRVTSILSSLTVTSLLRKLHAWINGDWSTPC
6j-C_0667 AEGASQWMNRLIAFASRGNHVSPTHYVPETDTSQKITNILSSLTVTSLLRKLHAWINGDWSTPC
6c-Th846 TEGAAQWMNRLIAFASRGNHVSPTHYVPETDASRAVTTILSSLTITSLLRKLHEWINTDWSTPC
6g-JK046 SEGAAQWMNRLIAFASRGNHVSPTHYVPETDASRAVTNILSSLTITSLLRKLHHWITEDYATPC
6a-euhk2 AEGANQWMNRLIAFASRGNHVSPTHYVPETDASKNVTQILTSLTITSLLRRLHQWVNEDTATPC
6b-Th580 SEGANQWMNRLIAFASRGNHVSPTHYVPETDASNKVTQILSSLTITSLLRRLHQWIHEDTSTPC
7a-QC69 SEGVTQWMNRLIAFASRGNHVSPTHYIQDDDASKRVMGILSSLTITSLIKRVLAWAQTDYSAPC
Consensus **. *************** :****: : *:: : :* ***:* *:::: * : . **
NS4BCter GEGAVQWMNRLIAFASRGNHVSPTHYVPESDAAARVTAILSSLTVTQLLRRLHQWISSECTTPC
NS4BH1 GEGAVQWMNRLIAFASRG
NS4BH2 ILSSLTVTQLLRRLHQWI
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water-soluble quencher acrylamide [40]. Stern–Volmer plots for the
quenching of Trp by acrylamide, recorded in the absence and}
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Fig. 1. (A) Change on the ﬂuorescence intensity of the Trp residue of the NS4BCter peptide in t
of the ﬂuorescence of the Trp residue of the NS4BCter peptide in the presence of acrylamide
the Trp residue of the NS4BCter peptide in the presence of 5-NS (ﬁlled symbols) and 16-NS (e
ratio of 5:1 (♦), EPC/Chol at a molar ratio of 5:1(Y ), BPS/Chol at a molar ratio of 5:1 (a), EPC
molar ratio of 5:3:1 (○), EPC/ESM/Chol at a molar ratio of 5:1:1 (▽), EPC/ESM/Chol at a mol
branes (▲). Peptide in buffer is represented by (+) in panel (B). The lipid compositi
59:0.37:7.4:18:3.1:1.2:3.4:7.8. Vertical bars indicate standard deviations of the mean of tri
and both 5- and 16-NS probes.presence of lipid vesicles, are shown in Fig. 1B and the resultant
Stern–Volmer constants are presented in Table 2. The Trp residues
are fairly accessible to acrylamide since linear Stern–Volmer plots06 0.09 0.12 0.00 0.05 0.10 0.15 0.20
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he presence of increasing lipid concentration, (B) Stern–Volmer plots for the quenching
and (C) Stern–Volmer plots for the depth-dependent quenching of the ﬂuorescence of
mpty symbols) probes. The lipid compositions used were EPC (■), EPA/Chol at a molar
/EPA at a molar ratio of 5:2 ( ), EPC/BPS at a molar ratio of 5:2 ( ), EPC/BPS/Chol at a
ar ratio of 5:3:1 (●), EPC/TPE/Chol at a molar ratio of 5:3:1 (□) and synthetic ER mem-
on of the synthetic ER was EPC/CL/BPI/TPE/BPS/EPA/ESM/Chol at a molar ratio of
plicate samples. The lipid to peptide ratio was 50:1 for experiments using acrylamide
Table 2
Partition coefﬁcients (Kp) and Stern–Volmer quenching constants (KSV) obtained from
the ﬂuorescence of the Trp residues of the NS4BCter peptide in buffer and in the pres-
ence of different model membranes.
LUV composition Kp (×10−6 M−1) KSV (M−1) KSV (M−1) KSV (M−1)
Trp Acrylamide 5-NS 16-NS
EPC 0.74±0.10 7.48±0.10 11.11±1.62 7.25±2.58
EPC/Chol 5:1 3.74±0.39 4.20±0.08 12.30±0.52 8.63±0.60
EPC/BPS 5:2 – 6.08±0.27 – –
EPC/EPA 5:2 0.57±0.28 4.07±0.09 16.84±1.97 11.06±1.58
EPA/Chol 5:1 3.35±0.53 2.86±0.04 7.45±1.55 3.60±2.13
BPS/Chol 5:1 6.03±1.96 3.76±0.04 – –
EPC/ESM/Chol 5:1:1 3.80±0.39 2.60±0.08 – –
EPC/ESM/Chol 5:3:1 1.39±0.50 4.14±0.11 6.31±0.23 6.08±0.48
EPC/BPS/Chol 5:3:1 2.62±0.90 – – –
EPC/TPE/Chol 5:3:1 4.00±1.70 – – –
ER complex mixture 0.60±0.33 5.58±0.09 9.90±0.33 8.26±0.42
Buffer 9.35±0.10 – –
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peptide Trp residue showed an acrylamide dependent concentration
behavior. In aqueous solution the Trp residues were highly exposed
to the solvent that led to a more efﬁcient quenching. However, in
the presence of the phospholipid membranes, the extent of
quenching was signiﬁcantly reduced, indicating a poor accessibility
of the Trp residues to the aqueous phase, consistent with its incorpo-
ration into the lipid bilayer. For the NS4BCter peptide, the extent of
quenching was signiﬁcantly reduced in the presence of Chol con-
taining membranes, in accordance with the results shown above.
The transverse location (penetration) of the NS4BCter peptide in the
lipid bilayer was evaluated by monitoring the relative quenching of
the ﬂuorescence of the Trp residue by the lipophilic spin probes
5-NS and 16-NS when the peptide was incorporated in the ﬂuid
phase of vesicles having different phospholipid compositions
(Fig. 1C), whereas the KSV values for both probes are presented in
Table 2. In general, 16-NS quenches the peptides ﬂuorescence less ef-
ﬁciently than 5-NS, but the difference between the two probes is not
very high. This data allows us to conclude that the Trp residue resides
in between these probes, but nearer to the 5-NS probe than to the
16-NS. These results are similar to those previously found for the
NS4BH1 and NS4BH2 peptides [25,26]. If we suppose that the
ﬂuorescence intensity of the Trp residues is related to the peptide
location in the membrane [38], the peptide would insert more
deeply in membranes containing Chol than on membranes without
it. The NS4BCter peptide has a positive net formal charge of +1.2 at
neutral pH, but there is no clear data to infer that surface charge
inﬂuences peptide binding to the membrane.
To explore the possible interaction of the NS4BCter peptide with
phospholipid model membranes, the effect of the peptide on the re-
lease of encapsulated CF trapped inside model membranes was stud-
ied [25]. The extent of leakage observed at different lipid/peptide
ratios and the effect of lipid composition are shown in Fig. 2A. The
NS4BCter peptide was able to induce the release of the internal con-
tents of the liposomes in a dose-dependent manner and the observed
effect was signiﬁcantly different for different lipid compositions. The
NS4BCter peptide induced a signiﬁcant percentage of leakage for lipo-
somes composed of EPC/18BMP at a molar ratio of 5:2, since at a lipid/
peptide ratio of 300:1 or lower the observed leakage was 100% and at
a lipid/peptide ratio of 500:1 the leakage value was 92% (Fig. 2A). Li-
posomes composed of synthetic late endosome compositions (LEM)
elicited signiﬁcant leakage effects, since they induced a 100% leakage
at a lipid/peptide ratio of 200:1. Higher lipid to peptide ratios induced
also signiﬁcant leakage values since 73%–66% and 48%–46% were ob-
served for 300:1 and 500:1 lipid to peptide ratios, respectively. Inter-
estingly, Chol addition to the LEM composition lowered the observed
leakage values (Fig. 2A). Lower but signiﬁcant leakage values were
observed for EPC/EPA at a molar ratio of 5:2 and EPC compositions,since 58% and 53% leakage values, respectively, were observed for
300:1 lipid/peptide ratios. At this lipid to peptide molar ratio, a leak-
age value of 34% was observed for EPC/ESM/Chol at a molar ratio of
5:1:1, 28% for BPS/Chol at a molar ratio of 5:2, 26% for EPA/Chol at a
molar ratio of 5:2, 23% for EPC/TPE/Chol at a molar ratio of 5:3:1
and 20% for EPC/BPS at a molar ratio of 5:2. Similarly, and for EPC/
Chol at a molar ratio of 5:2 and for EPC/BPS/Chol at a molar ratio of
5:3:1, leakage values of 10% and 3% were observed, respectively
(Fig. 2A). Chol seems to lower the leakage elicited by the peptide,
since its addition to LEM, EPC, BPS, and EPA membrane compositions
induced lower leakage values. It is interesting to note that 18BMP
elicits the highest membrane rupture effects, since even at the
highest lipid to peptide molar ratio studied of 500:1, more than 90%
leakage was observed. These results also suggest that there is no sig-
niﬁcant difference between negatively-charged and zwitterionic
phospholipids containing membranes, but for 18BMP containing
membranes (Fig. 2A).
Fig. 2B shows the extent of leakage for liposomes composed of
different molar ratios of EPC, ESM and Chol (the active replication
complexes of HCV might be localized in lipid domains composed pre-
dominantly of ESM and Chol [41,42]). Signiﬁcant leakage values were
observed for EPC/ESM/Chol membranes at molar ratios of 5:5:1, since
leakage values of 79% and 77% were found at lipid/peptide ratios of
300:1 and 500:1, respectively. Lower but signiﬁcant values were ob-
served for EPC/ESM/Chol membranes at molar ratios of 5:4:1, since at
lipid/peptide ratios of 300:1 and 500:1 leakage values of 61% and 55%
were found, respectively. For EPC/ESM/Chol membranes atmolar ratios
of 5:3:1, 5:2:1 and 5:1:1 leakage values were observed between 11 and
34% at both lipid/peptide ratios (Fig. 2B). As a general trend it can be
observed that the higher the ESM content and the lower the Chol con-
tent, the higher the leakage values are.
Since the NS4B protein is associated with membranes of the ER or
an ER-derivedmodiﬁed compartment [17], we have studied the effect
of the NS4BCter peptide on membrane rupture using a complex lipid
composition resembling the ER membrane as well as the effect of
each component of the complex mixture (Fig. 2C). Since the synthetic
ER complex membrane was composed of EPC, CL, BPI, TPE, BPS, EPA,
ESM and Chol at a molar ratio of 59:0.37:7.4:18:3.1:1.2:3.4:7.8 [30],
we have designed an ER synthetic membrane composed of EPC/CL/
BPI/TPE/BPS/EPA/ESM/Chol at a molar ratio of 58:6:6:6.6:6:6:6
(ER58:6). This synthetic ER membrane mixture includes lipids from
egg and brain sources, which are mixtures by themselves. However,
this complex lipid mixture is a good ER membrane model since the
ﬁrst step of the interaction between the peptides and the membrane
occurs at the membrane surface with the phospholipid headgroups.
Differences in the phospholipid hydrocarbon chains might be rele-
vant but at a later phase. As shown in Fig. 2C, the NS4BCter peptide
was capable of rupturing both synthetic ER membranes, since, at
lipid/peptide ratios of 200:1, 300:1 and 500:1, about 35–25% and
26–21% of leakage was attained for both ER and ER58:6 compositions.
Removing either BPI, TPE or BPS leakage values increased to about
70–60%, whereas removing either Chol, CL or EPA leakage values in-
creased to about 50–40% (Fig. 2C). However, the removal of ESM
did not show any signiﬁcant difference with both ER and ER58:6
compositions.
As we have noted above, the NS4BCter peptide comprises the
whole C-terminal domain of NS4B, which at the same time contains
segments H1 and H2. These two segments were previously studied
by us [25,26], but not all membrane compositions which have been
used for the NS4BCter peptide were tested previously to study pep-
tides NS4BH1 and NS4BH2. Because of that, and in order to compare
leakage data from peptides NS4BH1 and NS4BH2 with data from the
NS4BCter peptide, we have additionally studied those membrane com-
positions which were not used previously with peptides NS4BH1 and
NS4BH2 (Fig. 3). The extent of leakage observed at different lipid/peptide
ratios for EPC/18BMP at amolar ratio of 5:2 aswell as LEMandLEM/Chol
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Fig. 2. Effect of the NS4BCter peptide on the release (membrane rupture) of CF for (A) general different lipid compositions, (B) lipid compositions containing different molar ratios of
EPC, ESM and Chol and (C) the ER58:6 complex lipid mixture (EPC/CL/BPI/TPE/BPS/EPA/ESM/Chol at a molar ratio 58:6:6:6:6:6:6:6) and its variations. The lipid compositions used
were (A) EPC (■), EPC/TPE/Chol at a molar ratio of 5:3:1 (□), EPC/BPS/Chol at a molar ratio 5:3:1 (●), EPC/ESM/Chol at a molar ratio of 5:1:1 (▽), EPC/BPS at a molar ratio of 5:2 (◊),
EPC/EPA at a molar ratio of 5:2 (Δ), EPC/18BMP at a molar ratio of 5:2 (■), EPA/Chol at a molar ratio of 5:1 (♦), EPC/Chol at a molar ratio of 5:1 (Y), BPS/Chol at a molar ratio of
5:1(a), synthetic ER membranes (▲), EPC/TPE/BPI/18BMP at a molar ratio 5:1:1:2 (Z) and EPC/TPE/BPI/18BMP/Chol at a molar ratio 5:1:1:2:2 (○), (B) EPC (■), EPC/ESM/Chol at a
molar ratio 5:1:1 (▽), EPC/ESM/Chol at a molar ratio 5:2:1 (▼), EPC/ESM/Chol at a molar ratio 5:3:1 (□), EPC/ESM/Chol at a molar ratio 5:4:1 (E ), EPC/ESM/Chol at a molar ratio
5:5:1 ( Y), and (C) synthetic ER membranes (Δ), ER58:6 (□), ER58:6 minus Chol (●), ER58:6 minus BPI (▲), ER58:6 minus TPE (▼), ER58:6 minus ESM (♦), ER58:6 minus BPS (Y), ER58:6
minus EPA (a) and ER58:6 minus CL ( ). The lipid composition of the synthetic ER was EPC/CL/BPI/TPE/BPS/EPA/ESM/Chol at a molar ratio of 59:0.37:7.4:18:3.1:1.2:3.4:7.8. The
lipid mixture EPC/TPE/BPI/18BMP corresponds to the synthetic late endosome composition. Vertical bars indicate standard deviations of the mean of triplicate samples. See text
for details.
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leakage for liposomes composed of EPC/18BMP at a molar ratio of 5:2
yet signiﬁcantly lower than that found for the NS4BCter peptide
(Fig. 3A). A similar trend was observed for LEM compositions, since
leakage values elicited by both NS4BH1 and NS4BH2 peptides were sig-
niﬁcantly lower than that found for the NS4BCter peptide. The extent of
leakage for liposomes composed of different molar ratios of EPC, ESM
and Chol in the presence of the NS4BH2 peptide is shown in Fig. 3B. Sig-
niﬁcant leakage values were observed for EPC/ESM/Chol membranes at
molar ratios of 5:1:2, 5:2:1 and 5:2:2, as well as EPC and EPC/ESM at a
molar ratio of 5:2. However, lower values were found for EPC/Chol mix-
tures at various molar ratios, which indicated that the presence of ESM
was essential to elicit a signiﬁcant leakage effect. We have also studied
the leakage effect elicited by the NS4BH2 peptide on each ER component
of the ER58:6 complex mixture (Fig. 3C). As shown in the ﬁgure, leakage
values observed for the ER58:6 mixture were similar to those obtained
with the NS4BCter peptide. However, removal of either CL, Chol, EPA orBA
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moval of BPI did not produce any signiﬁcant effect.
Membrane lipids undergo a cooperative melting reaction, which is
linked to the loss of conformational order of the lipid chains and this
melting process is inﬂuenced by many types of molecules including
peptides and proteins. The effect of the NS4BCter peptide on the struc-
tural and thermotropic properties of phospholipid membranes was
investigated by measuring the steady-state ﬂuorescence anisotropy
of the ﬂuorescent probes DPH and TMA-DPH incorporated into
model membranes composed of different types of phospholipids as
a function of temperature (Fig. 4). Their different locations and orien-
tation in the membrane allow the analysis of the effect of the NS4BCter
peptide on the structural and thermotropic properties along the full
length of the membrane. When DMPC, DMPG, and DMPA were stud-
ied in the presence of the NS4BCter peptide, there was no signiﬁcant
change in the cooperativity of the thermal transition, and neither Tm
nor the anisotropy of both DPH and TMA-DPH above and below TmC
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plex ER mixture was assayed (in this case, EPC was substituted by
DMPC), the NS4BCter peptide abolished completely the small transi-
tion which was apparent in the pure lipid mixture and induced a
small decrease in anisotropy below the Tm of the mixture for the
DPH-containing sample (Fig. 4A and B). The effect of the three pep-
tides, i.e., NS4BCter, NS4BH1 and NS4BH2, on two phospholipids, name-
ly PSM and 14BMP, was also studied. NS4BCter did not induce any
signiﬁcant change in the cooperativity of the thermal transition of
PSM but induced a shift of the Tm of about 5 °C to lower temperatures
(Fig. 4C and D). However, the cooperativity of the main transition of
14BMP was decreased signiﬁcantly by NS4BCter, presenting 14BMP a
greatly broadened phase transition (Fig. 4E and F). The anisotropy ofboth ﬂuorescent probes was not signiﬁcatively changed by NS4BCter
above and below the Tm of both phospholipids. NS4BH1 induced a slight
shift of the Tm of about 2–3 °C to lower temperatures but did not change
signiﬁcantly the cooperativity of the PSM thermal transition (Fig. 4G
andH). The anisotropy of bothﬂuorescent probeswas slightly increased
above and below the Tm of PSM. In the case of 14BMP, NS4BH1 induced a
shift of about 5–6 °C of the Tm to lower temperatures as well as a de-
crease in cooperativity (Fig. 4I and J). For 14BMP, the anisotropy of
both ﬂuorescent probes was slightly increased above but not below
the Tm of 14BMP. The NS4BH2 peptide induced a shift of the Tm of PSM
of about 4–5 °C to lower temperatures as well as a slight decrease in
the cooperativity of the thermal transition of the phospholipid (Fig. 4K
and L). The anisotropy of both ﬂuorescent probes was increased
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duced a signiﬁcant shift of the transition temperature of about 12 °C
to lower temperatures along with a slight decrease in cooperativity
(Fig. 4M and N). The anisotropy of TMA-DPH was increased above
the Tm of 14BMP but it was not so apparent for the DPH probe.
The three peptides, i.e., NS4BCter, NS4BH1 and NS4BH2, were capable
of affecting the thermal transition Tm for these phospholipids as ob-
served by both types of probes and therefore should be located atDMPC
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PSM + NS4BCter
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Fig. 5. Differential scanning calorimetry heating-scan thermograms for model membranes c
presence of NS4BCter, NS4BH1 and NS4BH2 peptides as indicated. The peptide to phospholipid
molar ratio of 1:35 and 1:25, respectively. All thermograms were normalized to the same athe lipid–water interface inﬂuencing the ﬂuidity of the phospho-
lipids [43].
We have also studied the effect of the NS4BCter peptide on the ther-
motropic phase behavior of phospholipid multilamellar vesicles using
differential scanning calorimetry (DSC) and the corresponding proﬁles
are shown in Fig. 5. DMPC and DMPG, which have not been extensively
annealed at low temperatures, display two endothermic peaks on
heating, the pre-transition (appearing at about 12–14 °C, Lβ′–Pβ′) andDMPA + NS4BCter
BMP + NS4BH1
BMP + NS4BH2
BMP + NS4BCter
BMP + NS4BCter
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omposed of (A) DMPC, (B) DMPG, (C) DMPS, (D) DMPA, (E) PSM and (F) 14BMP in the
molar ratio was 1:15 except NS4BCter35 and NS4BCter25 which had a peptide to phospholipid
mount of lipid.
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in Fig. 5A, incorporation of NS4BCter in DMPC at a lipid/peptide ratio of
15:1 signiﬁcantly altered the thermotropic behavior of the phospholipid,
since the peptide abolished completely the pre-transition, as well as
signiﬁcatively broadened the main transition of DMPC. The main transi-
tion is apparently composed of at least two different peaks, which should
be due to mixed phases. A similar effect was elicited by the peptide on
DMPG, since NS4BCter abolished the pre-transition of DMPG and
signiﬁcatively broadened its main transition, indicating the presence of
more than one phase (Fig. 5B). DMPS and DMPA present a single highly
cooperative phase transition that corresponds to the chain melting tran-
sition from the gel to the liquid-crystalline phases [44]. The presence of
NS4BCter at a lipid/peptide molar ratio of 15:1 induced a slight decrease
of cooperativity in DMPS and a small broadband was visible at slightly
lower temperatures than that of the main transition (Fig. 5C). In the
case of DMPA, NS4BCter induced a shift to lower temperatures of the
main transition peak of the phospholipid but no decrease in coopera-
tivity is observed (Fig. 5D). PSM presents a single highly cooperative
phase transition at about 41 °C corresponding to the gel-to-liquid-
crystalline phase main transition. The incorporation of NS4BCter into
PSMmembranes at a lipid/peptide ratio of 15:1 altered the thermotrop-
ic behavior of the phospholipid, inducing a broadening of the main
transition peak (Fig. 5E). However, the incorporation of NS4BH2 in-
duced a more signiﬁcant effect, since it signiﬁcatively broadened
the main transition and induced the appearance of at least two dif-
ferent peaks (Fig. 5E). 14BMP, as observed in Fig. 5F, displays two en-
dothermic peaks on heating, a small transition at about 19 °C from a
quasi-crystalline phase Lc1 to a quasi-crystalline phase with different
tilt angle Lc2 and a main transition at about 41 °C from a quasi-
crystalline phase Lc2 to the liquid phase Lα [45]. The incorporationEPC/ESMECP
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Fig. 6.MAS 31P NMR spectra at 20 °C and 8 kHz spinning speed (500 MHz proton frequenc
Chol at a molar ratio of 5:3:3 in the presence of peptides NS4BH1, NS4BH2 and NS4BCter at a
differences are shown. The inset displays the normalized change in peak area for samples co
ratio of 5:3:3.of either NS4BH1 or NS4BH2 into 14BMP membranes at a lipid/peptide
ratio of 15:1 altered the thermotropic behavior of the phospholipid,
inducing the appearance of a small broadband at slightly lower
temperatures than that of the main transition as well as broadening it
(Fig. 5F). However, a complex behavior was observed when NS4BCter
was incorporated in 14BMP, since several peaks dissimilar from
the main transition peak were apparent at different temperatures
(Fig. 5F). These different peaks should be due to mixed phases induced
by the presence of the peptide. The coexistence of different phases in-
duced by the presence of the peptides would indicate that at least one
of them should be enriched in peptide whereas the others are not, i.e.,
phospholipids highly disturbed and phospholipids slightly disturbed,
respectively.
We have used MAS 31P NMR to observe mixtures of EPC, ESM and
Chol since the 31P NMR isotropic chemical shifts of both ESM and EPC
head-group peaks are resolvable under MAS conditions. Furthermore,
their spectral intensities reﬂect the molar ratio of each lipid in the mix-
ture so that it is straightforward to distinguish each phospholipid in the
spectra, allowing the observation of the line widths of each phospholip-
id component in themixture. As observed in Fig. 6, the chemical shift for
the EPC and ESM resonances was not signiﬁcantly different neither in
the absence nor in the presence of the peptides, but the line widths of
the 31P resonances of EPC and ESM were dissimilar depending on the
sample. For pure EPC, only one band was visible since only one type of
phospholipid was present. The presence of the peptides induced an in-
crease of thewidth of the band since for pure EPC it was 45 Hzwhereas
it was 56, 56 and 62 Hz in the presence of NS4BH1, NS4BH2 andNS4BCter,
respectively. However, they did not induce the presence of more than
one peak. When the mixtures EPC/ESM at a molar ratio of 5:3 and
EPC/ESM/Chol at a molar ratio of 5:3:3 were studied, they presentedEPC/ESM/Chol
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+ NS4B
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(Fig. 6). The presence of the peptides did not induce the appearance of
new peaks, but they induced a speciﬁc broadening depending on the
peptide studied. In the absence of the peptides, the width of the EPC
and ESM peaks in the EPC/ESMmixture was 42 and 43 Hz, respectively.
When NS4BH1, NS4BH2 and NS4BCter were present, the width of the EPC
and ESM peaks increased to 60 and 58 Hz, 58 and 66 Hz and 71 and
98 Hz, respectively (Fig. 6). Interestingly, the presence of the peptides
induced an increase in the width of the two EPC and ESM peaks, but
much more signiﬁcant for ESM in the presence of the NS4BCter peptide.
The width of the EPC and ESM peaks in the EPC/ESM/Chol mixture and
in the absence of the peptides was 44 and 47 Hz, respectively. The
width of the EPC and ESM peaks was 44 and 44 Hz, 52 and 48 Hz and
58 and 61 Hz, respectively, when NS4BH1, NS4BH2 and NS4BCter were
present (Fig. 6). In this case, only NS4BH2 and NS4BCter peptides were
capable of inducing a slight increase in width for the two peaks, where-
as NS4BH1 did not elicit a signiﬁcant change in width for the two phos-
pholipid peaks. The inset of Fig. 6 demonstrates that the peptides
induced a signiﬁcant effect on the EPC/ESM sample compared to the
EPC and EPC/ESM/Chol, as well as peptide NS4BCter is the one which
produces the most signiﬁcant change in width for all the mixtures.
The existence of structural changes on the NS4BCter peptide in-
duced by membrane binding was studied by analyzing the infrared
Amide I′ band located between 1700 and 1600 cm−1. The Amide I′
region of the fully hydrated peptide in buffer is shown in Fig. 7A.
For the peptide in solution and at low temperatures, the broad
Amide I′ band was slightly asymmetric with a maximum at about
1647 cm−1. The broadband with the intensity maxima at about
1647 cm−1 would mainly correspond to a mixture of unordered
and helical structures [46]. Increasing the temperature, the
Amide I′ band with the maximum at 1647 cm−1 slightly broad-
ened but did not change in frequency. At high temperatures a band
at approximately 1618 cm−1 concomitantly with a shoulder at about
1680 cm−1 was observed, which indicated the existence of aggregated
structures. Therefore theNS4BCter peptidewould change fromamixture1700 1600
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Fig. 7. Stacked infrared spectra in the C_O and Amide I′ region for the NS4BCter peptide (A
different temperatures as indicated. The pure phospholipid is shown on the left whereas the
ratio was 15:1.of helical and unordered structures at low temperatures to a mixture of
helical, unordered, and aggregated structures at high temperatures, this
transitional change in overall structure occurring at about 68–69 °C
(Fig. 7A).
In the presence of DMPC the Amide I′ envelope of the NS4BCter
peptide presented a broadband with maximum at about 1647 cm−1,
similarly to what was observed for the peptide in solution; however,
two bands at about 1680 and 1618 cm−1 were present at all tempera-
tures studied (Fig. 7B). The intensity of these two bands increased
with temperature while at the same time the main Amide I′ band de-
creased in intensity, but no change in frequency was observed. These
changes in band intensity show that in the presence of DMPC the NS4B-
Cter peptide presents a mixture of unordered, helical and aggregated
structures at all temperatures, with a higher percentage of aggregated
structures at higher temperatures. The maximum of the ester C_O
band of DMPC displayed two transitions, a smaller one between 14–
15 °C and another one at about 24 °C, coincident with the
pre-transition and the main gel to liquid crystalline phase transition of
the pure phospholipid (Fig. 8A). In the presence of NS4BCter, the ester
C_O band of DMPC displayed only one relatively broad transition at
about 24 °C, in accordance with the DSC data (see Fig. 5A). Derivation
of the broad C_O ester band revealed that it was formed by two main
bands appearing at about 1743 cm−1 and 1727 cm−1, assigned to the
free and hydrogen-bonded ester carbonyl groups [47,48] (Fig. 8A). In
the presence of NS4BCter, the frequency maximum of the ester band
was at a higher frequency than that of the pure phospholipid indicating
that the amount of non-hydrogen bondedC_Oester bands increased in
the presence of the peptide.
In the presence of DMPG and at all temperatures, the Amide I′
envelope of NS4BCter was similar to that observed for the peptide in
solution at relatively low temperatures, i.e., a broadband with a max-
imum at about 1646 cm−1 (Fig. 7C). Interestingly, no bands at about
1680 and 1617 cm−1 were apparent at any temperatures. Therefore,
NS4BCter, in the presence of DMPG, presents a mixture of mainly
unordered and helical structures at all temperatures. This dataC
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Fig. 8. Temperature dependence of the frequencies of the C_O carbonyl stretching bands for samples of (A) DMPC, (B) DMPG, (C) DMPA and (D) 14BMP in the pure form (■) and in
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but only in the presence of DMPG. DMPG, a phosphatidylglycerol
phospholipid, can exhibit under physiologically relevant conditions
a more complex pattern of thermotropic phase behavior than the
corresponding zwitterionic DMPC which we have commented
above, including the formation of one or more high melting crystal-
line or quasi-crystalline lamellar phases and the formation of extend-
ed three-dimensional bilayer networks where curvature elasticity is
of primary relevance [49,50]. The pattern of thermotropic phase be-
havior exhibited by freshly dispersed samples of DMPG is remarkablysimilar to that of DMPC (compare Fig. 8A and B). However, incubation
of phosphatidylglycerols at low temperatures results in the formation
of one or more quasi-crystalline structures at rates dependent on the
hydrocarbon chain length, i.e., Lc1b and Lc2 phases [49,50]. The ester
C_O band of DMPG in the presence of NS4BCter presented a broadband
with different components depending on temperature (Fig. 8B). At low
temperatures two relatively sharp bands appeared at about 1742 and
1735 cm−1 as well as a broadband at about 1722 cm−1. Increasing
the temperature the two sharp bands shifted to 1739 and 1737 cm−1
and the broadband, maintaining its frequency, sharpened (Fig. 8B). At
2547M.F. Palomares-Jerez et al. / Biochimica et Biophysica Acta 1818 (2012) 2536–2549higher temperatures, a broad C_O band similar to that found at low
temperatures was apparent again. These two changes delimited two
transitions, one at about 17 °C and another one at about 28 °C. The ap-
pearance of these sharp C_O bands in DMPG suggests that a new
phase, likely the Lc1b phase, is induced by the presence of the NS4BCter
peptide.
The Amide I′ envelope of NS4BCter in the presence of DMPA was
similar to that observed for the peptide in solution at low tempera-
tures, i.e., a broadband with a maximum at about 1646 cm−1
(Fig. 7D). No bands at about 1680 and 1617 cm−1 were apparent at
any temperatures. In this case, and similarly to what was observed
in the presence of DMPG, NS4BCter presents a mixture of unordered
and helical structures with a high degree of conformational stability.
The maximum of the ester C_O band of DMPA changed from
1738 cm−1 to 1728 cm−1 at about 50 °C, i.e., the gel to liquid crystal-
line phase transition, in accordance with the DSC data (Fig. 8C). In the
presence of NS4BCter, the ester C_O band of DMPA displayed two
transitions, one at 48 °C and a broad one between 50 °C and 58 °C.
Derivation of the broad C_O ester band revealed that at low temper-
atures it was formed by two main bands at about 1741 cm−1 and
1723 cm−1, i.e., the free and hydrogen-bonded ester carbonyl groups.
These bands shifted to about 1743 cm−1 and 1726 cm−1 at about
48 °C, changing slightly in intensity above it, this intensity change
deﬁning the broad transition that was observed between 50 °C and
58 °C.
In the presence of 14BMP and at all temperatures, the Amide I′ en-
velope of NS4BCter was much broader than that observed for the pep-
tide in solution (Fig. 7E). At low temperatures the Amide I′maximum
appeared at about 1647 cm−1, similarly to that observed for the pep-
tide in solution. However, a shoulder at about 1680 cm−1 not accom-
panied by another band at 1618 cm−1 was also apparent, which
might be indicative of the existence of β-turn structures. At higher
temperatures, a shoulder with a maximum at about 1618 cm−1 was
observed, indicating the presence of aggregated structures. The
ester C_O band of pure 14BMP displayed a sharp band at low tem-
peratures, with a maximum at about 1735 cm−1 (Figs. 7E and 8D).
At about 34 °C it began to broaden due to the appearance of a band
at about 1724 cm−1, this band increasing in intensity as the temper-
ature increased, thereby inducing a decrease of the maximum of the
band at 1735 cm−1. The appearance of this new band and the broad-
ening of the previous one should be related to the transition from a
quasi-crystalline phase Lc2 to the liquid phase Lα as commented
above. In the presence of NS4BCter, the ester C_O band of 14BMP dis-
played a relatively broad transition at about 53 °C (Fig. 8D). The C_O
band at low temperatures was formed by at least three components,
which after derivation presented frequencies of about 1739 cm−1,
1732 cm−1 and 1724 cm−1, whose intensity depended on tempera-
ture. However and at higher temperatures than 53 °C, these bands co-
alesced into two sharp bands with frequencies of 1742 cm−1 and
1730 cm−1 (Fig. 8D).
4. Discussion
The replication and assembly of HCV have been suggested to occur
in host-derived membranes where different HCV and cellular pro-
teins play a central role in the viral life cycle [51]. However, the func-
tion, location, protein–protein and protein–lipid interactions of the
viral individual proteins remain poorly understood. NS4B is a highly
hydrophobic protein which has been suggested to alter intracellular
host membranes making possible the formation of the HCV replica-
tion complex. If that were true, NS4B would play a critical role in
HCV life cycle. The C-terminal region of NS4B is likely to be an impor-
tant region in the protein, signiﬁcantly conserved among the major
genotypes of HCV. Its ultimate signiﬁcance is demonstrated by the
fact that the introduction of mutations into this fragment abolishes
HCV RNA replication. Inside the C-terminal region there are twoα-helical elements which interact with membranes [25,26]. There-
fore we have studied a peptide comprising the C-terminal region of
NS4B, the NS4BCter peptide, and compared the obtained data with
that of the two α-helical elements, the NS4BH1 and NS4BH2 peptides,
providing evidence of the speciﬁc interaction between the NS4B
C-terminal region with model membranes.
Peptide NS4BCter binds with high afﬁnity to phospholipid model
membranes, as it has been previously found for other peptides [39].
Binding of NS4BCter to liposomes was further demonstrated by the
use of hydrophilic quenching probes, since NS4BCter was less accessi-
ble for quenching by acrylamide implying a buried location. The lipo-
philic probe quenching results suggest a shallow-to-intermediate
location of the peptide in the membrane, considering that the extent
of quenching was reduced but its absolute values were relatively low
compared to other peptides [52]. Interestingly, Chol would induce a
deeper insertion of the peptide in the membrane. Furthermore, pep-
tide charge would not affect its location inside the membrane. We
have also shown that the NS4BCter peptide is capable of affecting the
steady state ﬂuorescence anisotropy of ﬂuorescent probes located in
the palisade structure of the membrane. Calorimetry experiments
further corroborated these results, and additionally indicated that
the NS4BCter peptide induced the presence of mixed lipid phases,
enriched and impoverished in peptide. This result strengthens the
idea that the location of the C-terminal region of NS4B is at or near
the membrane interface, inﬂuencing the ﬂuidity of the phospholipids,
most probably with an in-plane orientation rather than in a trans-
membrane position [53]. This location would be in accordance with
previous data obtained for the two proposed α-helical elements of
the C-terminal region [25,26].
The NS4BCter peptide was capable of altering membrane stability
causing the release of ﬂuorescent probes, this effect being dependent
on the lipid/peptide molar ratio and on lipid composition. The highest
CF release was observed for liposomes containing the phospholipid
BMP, although signiﬁcant leakage values were also observed for lipo-
somes composed of both zwitterionic and negatively-charged phos-
pholipids. Even at a lipid to peptide molar ratio of 300:1, a 100%
leakage value was attained in BMP membranes. Interestingly, Chol
seems to lower the leakage elicited by the peptide, since its addition
to different membrane compositions induced lower leakage values.
As a general trend it can be observed that the higher the ESM content
and the lower the Chol content, the higher the leakage values are. The
MAS 31P NMR results show that both phospholipids, EPC and ESM,
exhibit a lower degree of mobility in the presence of the peptides
but in the absence of Chol [54]. These differences could be a conse-
quence of the inﬂuence of Chol in the membrane penetration of
peptides attenuating its insertion as it has been observed for other
peptides [55]. The speciﬁc disrupting effect elicited by the NS4BCter
peptide should be due primarily to hydrophobic interactions within
the bilayer, although the speciﬁc charge of the phospholipid
head-groups affects, albeit slightly, the extent of membrane leakage.
These results were corroborated by using a speciﬁc ER complex
membrane.
The infrared spectra of the Amide I′ region of the fully hydrated
peptide in solution at low temperatures displayed a coexistence of
unordered and helical structures, which at high temperatures became
a mixture of helical, unordered, and aggregated structures. In the
presence of different types of phospholipids as well as at different
temperatures, different secondary structures in varying amounts
were found. At the same time, differences in the frequency and num-
ber of bands corresponding to the carbonyl band of the phospholipids
were observed. However, in the presence of membranes, it did not
change, demonstrating a high stability of conformation in the bound
state. These results imply that the secondary structure of the NS4BCter
peptide was affected by its binding to the membrane, so that mem-
brane binding modulates the secondary structure of the peptide as
it has been suggested for other peptides [26,56].
2548 M.F. Palomares-Jerez et al. / Biochimica et Biophysica Acta 1818 (2012) 2536–2549The binding of peptide NS4BCter to the surface of the membrane
and the modulation of the phospholipid biophysical properties
which takes place as a consequence of binding i.e., partitioning into
the membrane surface and perturbation of the bilayer architecture,
could be related to the conformational changes which might occur
during the biological activity of the NS4B protein. Our results add
new information about how this region can contribute to the interac-
tion with the membrane, a necessary step in the viral replication
cycle. Although the peptide is not deeply buried in the membrane,
its interaction with the membrane depends on its composition and
it is able to affect the lipid milieu from the membrane surface down
to the hydrophobic core. Consequently, our results identify the full
C-terminal region of the HCV NS4B protein as a membrane interacting
domain, and therefore directly implicated in the HCV life cycle.Acknowledgements
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